Laura Bordone

4.2k total citations · 3 hit papers
30 papers, 3.1k citations indexed

About

Laura Bordone is a scholar working on Genetics, Geriatrics and Gerontology and Molecular Biology. According to data from OpenAlex, Laura Bordone has authored 30 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 9 papers in Geriatrics and Gerontology and 8 papers in Molecular Biology. Recurrent topics in Laura Bordone's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (14 papers), Sirtuins and Resveratrol in Medicine (9 papers) and Hemophilia Treatment and Research (7 papers). Laura Bordone is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (14 papers), Sirtuins and Resveratrol in Medicine (9 papers) and Hemophilia Treatment and Research (7 papers). Laura Bordone collaborates with scholars based in United States, Netherlands and Italy. Laura Bordone's co-authors include Leonard Guarente, Maria Carla Motta, Ashley Robinson, Dena E. Cohen, Nargis Nasrin, Javier Apfeld, Ulupi S. Jhala, Erin Easlon, Frédéric Picard and Madeleine E. Lemieux and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Laura Bordone

25 papers receiving 3.0k citations

Hit Papers

Calorie restriction, SIRT1 and metabolism: understanding ... 2005 2026 2012 2019 2005 2007 2005 250 500 750

Peers

Laura Bordone
Akiko Satoh United States
Lora B. Sweeney United States
Cuiying Xiao United States
Carrie A. Grueter United States
Danica Chen United States
Carlos Escande United States
Jinze Xu United States
Ulupi S. Jhala United States
Emanuele Loro United States
Akiko Satoh United States
Laura Bordone
Citations per year, relative to Laura Bordone Laura Bordone (= 1×) peers Akiko Satoh

Countries citing papers authored by Laura Bordone

Since Specialization
Citations

This map shows the geographic impact of Laura Bordone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Bordone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Bordone more than expected).

Fields of papers citing papers by Laura Bordone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Bordone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Bordone. The network helps show where Laura Bordone may publish in the future.

Co-authorship network of co-authors of Laura Bordone

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Bordone. A scholar is included among the top collaborators of Laura Bordone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Bordone. Laura Bordone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Witjes, Han, et al.. (2025). Exposure–Response Analysis of Donidalorsen for the Treatment of Hereditary Angioedema. Clinical and Translational Science. 18(11). e70388–e70388.
2.
Riedl, Marc A., Jonathan A. Bernstein, Raffi Tachdjian, et al.. (2025). Patient-Reported Injection-Site Pain And Treatment Satisfaction After Switching From Long-Term Prophylaxis To Donidalorsen For The Treatment Of Hereditary Angioedema: Results From The OASISplus Study. Journal of Allergy and Clinical Immunology. 155(2). AB193–AB193. 1 indexed citations
3.
Broderick, Lynne, et al.. (2025). The adolescent experience of hereditary angioedema: a qualitative study of disease burden and treatment experience. Orphanet Journal of Rare Diseases. 20(1). 16–16.
4.
Cohn, Danny M., Aaron Yarlas, Jakob B. Bjorner, et al.. (2025). Improvements In Quality-Of-Life In Patients With HAE Receiving Donidalorsen: Post Hoc Analysis From The OASIS-HAE Study. Journal of Allergy and Clinical Immunology. 155(2). AB211–AB211.
5.
Broderick, Lynne, et al.. (2025). Content validation of the Angioedema Quality of Life Questionnaire (AE-QoL) in a population of adult and adolescent patients with hereditary angioedema (HAE). Journal of Patient-Reported Outcomes. 9(1). 42–42. 1 indexed citations
6.
Riedl, Marc A., et al.. (2025). Patient‐Reported Outcomes in the Phase III OASIS‐HAE Study of Donidalorsen for Hereditary Angioedema. Allergy. 80(8). 2361–2368. 3 indexed citations
7.
Villa, Kathleen F., et al.. (2025). Patient Preferences for Attributes of Prophylactic Treatment in Hereditary Angioedema: A Discrete-Choice Experiment. Journal of Allergy and Clinical Immunology. 155(2). AB228–AB228.
8.
Tachdjian, Raffi, Laura Bordone, Ken B. Newman, et al.. (2024). DONIDALORSEN FOR HEREDITARY ANGIOEDEMA: RESULTS FROM THE OASISPLUS OPEN-LABEL EXTENSION STUDY. Annals of Allergy Asthma & Immunology. 133(6). S38–S38. 1 indexed citations
9.
Manning, Michael, Laura Bordone, Danny M. Cohn, et al.. (2024). PHASE 2 OPEN-LABEL EXTENSION OF DONIDALORSEN IN PATIENTS WITH HEREDITARY ANGIOEDEMA: A WEEK 197 ANALYSIS. Annals of Allergy Asthma & Immunology. 133(6). S38–S38.
10.
Riedl, Marc A., Laura Bordone, Alexey S. Revenko, Ken B. Newman, & Danny M. Cohn. (2023). Clinical Progress in Hepatic Targeting for Novel Prophylactic Therapies in Hereditary Angioedema. The Journal of Allergy and Clinical Immunology In Practice. 12(4). 911–918. 6 indexed citations
11.
Nasrin, Nargis, et al.. (2010). SIRT4 Regulates Fatty Acid Oxidation and Mitochondrial Gene Expression in Liver and Muscle Cells. Journal of Biological Chemistry. 285(42). 31995–32002. 251 indexed citations
12.
Nasrin, Nargis, Virendar K. Kaushik, Daniel Wall, et al.. (2009). JNK1 Phosphorylates SIRT1 and Promotes Its Enzymatic Activity. PLoS ONE. 4(12). e8414–e8414. 223 indexed citations
13.
Bordone, Laura & Leonard Guarente. (2007). Sirtuins and β‐cell function. Diabetes Obesity and Metabolism. 9(s2). 23–27. 14 indexed citations
14.
Bordone, Laura, Dena E. Cohen, Ashley Robinson, et al.. (2007). SIRT1 transgenic mice show phenotypes resembling calorie restriction. Aging Cell. 6(6). 759–767. 587 indexed citations breakdown →
15.
Bordone, Laura, Maria Carla Motta, Frédéric Picard, et al.. (2005). Sirt1 Regulates Insulin Secretion by Repressing UCP2 in Pancreatic β Cells. PLoS Biology. 4(2). e31–e31. 585 indexed citations breakdown →
16.
Bordone, Laura & Leonard Guarente. (2005). Calorie restriction, SIRT1 and metabolism: understanding longevity. Nature Reviews Molecular Cell Biology. 6(4). 298–305. 820 indexed citations breakdown →
17.
Bordone, Laura & Colin Campbell. (2002). DNA Ligase III Is Degraded by Calpain during Cell Death Induced by DNA-damaging Agents. Journal of Biological Chemistry. 277(29). 26673–26680. 24 indexed citations
18.
Larson, Erin B., Lisa M. Schrott, Laura Bordone, & Sheldon B. Sparber. (2001). Embryonic cocaine exposure and corticosterone: Serotonin2 receptor mediation. Pharmacology Biochemistry and Behavior. 69(1-2). 71–75. 7 indexed citations
19.
Bordone, Laura, Lisa M. Schrott, & Sheldon B. Sparber. (1997). Ontogeny of Glucocorticoid Receptors in the Hyperstriatum‐Hippocampus‐Parahippocampal Area and Optic Tectumof the Embryonic Chicken (Gallus domesticus) Brain. Journal of Neuroendocrinology. 9(10). 753–761. 18 indexed citations
20.
Carrera, Paola, et al.. (1996). Point mutations in Italian patients with classic, non-classic, and cryptic forms of steroid 21-hydroxylase deficiency. Human Genetics. 98(6). 662–665. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026